Treatment Guideline Development and Implementation, An Issue of Rheumatic Disease Clinics of North America

Cover image

Title page

Table of Contents

Copyright

Contributors

Forthcoming Issues

Foreword

Preface

How the American College of Rheumatology Develops Guidelines

Key points

Introduction

American College of Rheumatology policies and procedures

Summary

The GRADE Method

Key points

GRADE background

Introduction to the basics of GRADE

Confidence in evidence

Criteria that reduce confidence in evidence

Criteria that increase confidence in evidence

Online tools and resources

Summary

Clinics care points

Taxonomy of Quality of Care Indicators: Tracing the Path from Clinical Practice Guidelines to Quality Measurement and Beyond

Key points

Background and definitions

What are some of the challenges with quality measurement?

Resources

Clinics care points

Recommendations for Systemic Lupus Erythematosus: Balancing Evidence and Eminence to Facilitate the Medical Care of a Complex Disease

Key points

Introduction

An overview of the recommendations for the management of systemic lupus erythematosus

Key differences among the systemic lupus erythematosus recommendations

Recommendations for lupus nephritis and important differences

Recommendations for other aspects in the management of systemic lupus erythematosus patients

Challenges in producing systemic lupus erythematosus recommendations

Recommendations versus usual care of patients with systemic lupus erythematosus

Systemic lupus erythematosus recommendations: Future perspectives

Clinics care points

Osteoarthritis Treatment Guidelines from Six Professional Societies: Similarities and Differences

Key points

Introduction

Methods

Results

Discussion

Summary

Clinics care points

Treatment Guidelines in Gout

Key points

Introduction

History

Background

Summary

Clinics care points

Appendix 1Case Study

Appendix 22016 European League Against Rheumatism Recommendations

Appendix 3AMERICAN COLLEGE OF RHEUMATOLOGY GUIDELINE.

Treatment Guidelines in Rheumatoid Arthritis

Key points

The purpose of treatment guidelines

History and the scope of key rheumatoid arthritis guidelines

Treatment of disease-modifying antirheumatic drug–naive patient with rheumatoid arthritis

Treatment of conventional synthetic disease-modifying antirheumatic drug–experienced patient with rheumatoid arthritis

Treatment of biologic or targeted synthetic disease-modifying antirheumatic drug–experienced patient with rheumatoid arthritis

Tapering of treatment in people with rheumatoid arthritis in low disease activity or remission

Treatment of patient with rheumatoid arthritis with significant comorbidities

Recent developments that may significantly impact the approach to rheumatoid arthritis treatment

Summary

Clinics care points

The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development

Key points

Introduction

Developing guidelines

Challenges in patient’s engagement in clinical practice guidelines development process

Patient values and preferences

Framework for enhancing clinical practice guidelines through continuous patient engagement along the entire clinical practice guidelines development process

Summary

Clinics care points

Treatment Guidelines in Vasculitis

Key points

Giant cell arteritis

Takayasu arteritis

Polyarteritis nodosa

Granulomatosis with polyangiitis and microscopic polyangiitis

Eosinophilic granulomatosis with polyangiitis

Summary

Treatment Guidelines in Pediatric Rheumatic Diseases

Key points

Introduction

Discussion

Summary

Clinics care points

The Evaluation of Guideline Quality in Rheumatic Diseases

Key points

Introduction

Summary

Clinics care points